Showing 1 - 10 of 13
Persistent link: https://www.econbiz.de/10005516418
Persistent link: https://www.econbiz.de/10005475538
Persistent link: https://www.econbiz.de/10009150439
Persistent link: https://www.econbiz.de/10008522393
From a third-party payer perspective, atypical antipsychotic mono-therapy generated higher drug costs but lower medical care costs, resulting in equivalent total healthcare costs over a 1-year period. </AbstractSection> Copyright Adis Data Information BV 2010
Persistent link: https://www.econbiz.de/10011000720
Given that it is still early days for the URBMI scheme, the positive effect on health services utilisation is appreciable. </AbstractSection> Copyright Springer International Publishing Switzerland 2014
Persistent link: https://www.econbiz.de/10011001662
Under the highly price-regulated market in China, competition from generic and therapeutic competitors did decrease pharmaceutical prices. Further research is needed to explore whether this competition increases consumer welfare in China’s healthcare setting. </AbstractSection> Copyright Springer International...
Persistent link: https://www.econbiz.de/10011001682
Previous research on corporate community involvement (CCI) initiatives indicates that such behaviour is critical for building neighbourhood relationships and extending corporate influence in the community, but there is little theoretical work that provides a clear picture of managing the nature...
Persistent link: https://www.econbiz.de/10010868029
Persistent link: https://www.econbiz.de/10010868160
The purpose of cause-related marketing is to capitalise on a firm’s social engagement initiatives to achieve a positive return on a firm’s social investment. This article discusses two strategic perspectives of cause-related marketing and their impact on a firm’s decision-making regarding...
Persistent link: https://www.econbiz.de/10010990093